Your browser is no longer supported. Please, upgrade your browser.
Settings
GTXI GTx, Inc. daily Stock Chart
GTXI [NASD]
GTx, Inc.
Index- P/E- EPS (ttm)-0.13 Insider Own25.50% Shs Outstand141.72M Perf Week-3.45%
Market Cap79.36M Forward P/E- EPS next Y-0.12 Insider Trans0.40% Shs Float43.29M Perf Month-3.45%
Income-14.20M PEG- EPS next Q-0.05 Inst Own10.90% Short Float1.92% Perf Quarter-20.00%
Sales- P/S- EPS this Y72.30% Inst Trans0.10% Short Ratio17.16 Perf Half Y-15.15%
Book/sh0.17 P/B3.29 EPS next Y-9.10% ROA-41.10% Target Price- Perf Year-47.66%
Cash/sh0.17 P/C3.27 EPS next 5Y0.00% ROE- 52W Range0.29 - 1.22 Perf YTD-20.00%
Dividend- P/FCF- EPS past 5Y-18.30% ROI- 52W High-54.10% Beta2.32
Dividend %- Quick Ratio8.80 Sales past 5Y- Gross Margin- 52W Low93.10% ATR0.04
Employees29 Current Ratio8.80 Sales Q/Q- Oper. Margin- RSI (14)39.07 Volatility7.14% 6.26%
OptionableYes Debt/Eq0.00 EPS Q/Q186.40% Profit Margin- Rel Volume0.75 Prev Close0.56
ShortableYes LT Debt/Eq0.00 EarningsAug 04 BMO Payout- Avg Volume48.49K Price0.56
Recom3.00 SMA20-4.11% SMA50-11.92% SMA200-22.83% Volume36,244 Change0.00%
Apr-05-13Initiated Stifel Buy $7
Oct-14-11Initiated Rodman & Renshaw Mkt Outperform $7
Jul-20-11Initiated Wedbush Outperform $13
Oct-27-10Upgrade Rodman & Renshaw Mkt Underperform → Mkt Perform
May-26-10Reiterated Rodman & Renshaw Mkt Underperform $1.75 → $1.25
Mar-17-10Downgrade Rodman & Renshaw Mkt Perform → Mkt Underperform $1.75
Jan-26-09Reiterated Leerink Swann Mkt Perform $18 → $10
Jan-22-09Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
May-23-08Downgrade Cowen & Co Outperform → Neutral
Mar-25-08Initiated Rodman & Renshaw Mkt Outperform $22
Nov-07-07Reiterated Lazard Capital Buy $28 → $31
Nov-06-07Reiterated Broadpoint Capital Buy $26 → $29
Oct-11-07Initiated Wachovia Outperform
Sep-13-07Initiated First Albany Buy $26
May-10-07Initiated Citigroup Hold $24
Apr-30-07Downgrade Leerink Swann Outperform → Mkt Perform
Apr-24-07Reiterated HSBC Securities Overweight $25 → $29
Apr-18-07Reiterated Lazard Capital Buy $25 → $28
Apr-18-07Reiterated AG Edwards Buy $23 → $28
Feb-26-07Reiterated Lazard Capital Buy $21 → $25
Jun-22-16 10:01AM  GTX INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tran
Jun-21-16 08:15AM  GTx (GTXI) Shows Strength: Stock Adds 11.2% in Session -8.82%
Jun-08-16 06:07PM  GTx, Inc. :GTXI-US: Earnings Analysis: Q1, 2016 By the Numbers : June 8, 2016
Jun-02-16 07:00AM  GTx Announces Webcast of Corporate Presentation at Jefferies 2016 Global Healthcare Conference Business Wire -8.45%
May-19-16 01:04PM  GTX INC /DE/ Financials
May-16-16 07:00AM  GTx Announces Webcast of Corporate Presentation at the UBS Global Healthcare Conference 2016 Business Wire
May-10-16 07:32AM  GTX INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:14AM  GTx posts 1Q profit
07:07AM  Q1 2016 GTX Inc Earnings Release - Before Market Open
07:00AM  GTx Provides Corporate Update and Reports First Quarter 2016 Financial Results Business Wire
May-09-16 05:16PM  GTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:00AM  GTx Announces Presentation of Preclinical Data Demonstrating the Ability of SARDs to Degrade and Inhibit the Androgen Receptor at the American Urological Association Annual Meeting Business Wire
Apr-27-16 07:00AM  GTx, Inc. to Report First Quarter 2016 Financial Results on May 10, 2016 Business Wire -6.58%
Apr-06-16 05:24PM  Edited Transcript of GTXI earnings conference call or presentation 3-Mar-16 2:00pm GMT
Mar-15-16 04:18PM  GTX INC /DE/ Files SEC form 10-K, Annual Report
Mar-03-16 09:00AM  GTX Inc Earnings Call scheduled for 9:00 am ET today -10.14%
07:31AM  GTX INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:17AM  GTx reports 4Q loss
07:07AM  Q4 2015 GTX Inc Earnings Release - Before Market Open
07:00AM  GTx Provides Corporate Update and Reports Fourth Quarter and Year-End 2015 Financial Results Business Wire
Feb-24-16 07:00AM  GTx Announces Presentation of Preclinical Data Demonstrating the Effect of GTx SARMs on Pelvic Floor Muscle Loss at the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU) Meeting Business Wire +6.25%
Feb-19-16 04:32PM  GTX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers
Feb-18-16 07:00AM  GTx, Inc. to Host Fourth Quarter and Full Year 2015 Financial Results Conference Call and Webcast Business Wire
Jan-13-16 09:56AM  GTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits -7.41%
07:00AM  GTx Announces Initiation of Phase 2 Clinical Trial of Enobosarm in Stress Urinary Incontinence Business Wire
Dec-23-15 05:01PM  GTX INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tran
Dec-16-15 08:20AM  Strength Seen in GTX (GTXI): Stock Adds 7.8% in Session -6.02%
Dec-01-15 09:05AM  Equities on the Move - Research on GTX Inc, Juniper Pharmaceuticals, Catabasis Pharmaceuticals and Amber Road Accesswire +5.38%
Nov-29-15 04:02AM  Is Jernigan Capital Inc (JCAP) a Good Stock To Buy? at Insider Monkey
Nov-26-15 07:40AM  Radio One, Inc. (ROIAK): Are Hedge Funds Right About This Stock? at Insider Monkey
Nov-23-15 05:21PM  GTX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers
Nov-09-15 04:59PM  GTX INC /DE/ Files SEC form 10-Q, Quarterly Report
Nov-02-15 03:55PM  Edited Transcript of GTXI earnings conference call or presentation 29-Oct-15 1:00pm GMT
Oct-29-15 09:39AM  GTx posts 3Q profit
09:00AM  GTX Inc Earnings Call scheduled for 9:00 am ET today
07:31AM  GTX INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:07AM  Q3 2015 GTX Inc Earnings Release - Time Not Supplied
07:00AM  GTx Provides Corporate Update and Reports Third Quarter 2015 Financial Results Business Wire
Oct-15-15 07:00AM  GTx, Inc. To Host Third Quarter 2015 Financial Results Conference Call and Webcast Business Wire
Oct-13-15 07:31AM  GTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:00AM  GTx Receives FDA Clearance to Initiate Clinical Trial in Stress Urinary Incontinence Business Wire
Oct-07-15 08:15AM  GTX (GTXI) Shows Strength: Stock Adds 37.8% in Session -14.16%
Oct-06-15 07:32AM  GTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits +37.80%
07:00AM  GTx Announces Enrollment of First Patient in Phase 2 Clinical Trial of Enobosarm in Triple Negative Breast Cancer Business Wire
Sep-29-15 07:31AM  GTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:00AM  GTx Announces Enrollment of First Patient in Phase 2 Clinical Trial of Enobosarm in ER+/AR+ Breast Cancer Business Wire
Sep-21-15 10:39AM  GTx, Inc. breached its 50 day moving average in a Bullish Manner : September 21, 2015 -9.17%
Aug-21-15 09:42AM  Edited Transcript of GTXI earnings conference call or presentation 6-Aug-15 1:00pm GMT -8.79%
Aug-16-15 08:12PM  10-Q for GTx, Inc. at Company Spotlight
Aug-10-15 06:18PM  GTX INC /DE/ Files SEC form 10-Q, Quarterly Report +10.00%
Aug-06-15 03:39PM  GTx earnings released, explores SARM potential at bizjournals.com
09:00AM  GTX Inc Earnings Call scheduled for 9:00 am ET today
08:21AM  GTx reports 2Q loss
07:31AM  GTX INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:07AM  Q2 2015 GTX Inc Earnings Release - Time Not Supplied
07:00AM  GTx Provides Corporate Update and Reports Second Quarter 2015 Financial Results Business Wire
Jul-23-15 07:00AM  GTx, Inc. To Host Second Quarter 2015 Financial Results Conference Call and Webcast Business Wire
Jul-08-15 07:31AM  GTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:00AM  GTx Appoints Diane Young, M.D. as Vice President, Chief Medical Officer Business Wire
Jul-07-15 03:04PM  Which Memphis public company had the best year so far? at bizjournals.com -12.41%
Jun-30-15 10:35AM  Can the Uptrend Continue for GTx (GTXI)? - Tale of the Tape
Jun-23-15 01:20AM  Edited Transcript of GTXI earnings conference call or presentation 8-May-15 1:00pm GMT
Jun-09-15 08:34AM  Can The Uptrend Continue for GTx (GTXI)? - Tale of the Tape
Jun-02-15 06:31AM  GTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
06:00AM  GTx Regains Compliance with NASDAQ Bid Price Requirement Business Wire
May-26-15 07:00AM  GTx Announces Webcast of Corporate Presentation at Jefferies 2015 Global Healthcare Conference Business Wire
May-17-15 08:11PM  10-Q for GTx, Inc. at Company Spotlight
May-13-15 09:59AM  GTx (GTXI) Shares March Higher, Can It Continue? - Tale of the Tape
May-12-15 07:00AM  GTx Announces Webcast of Corporate Presentation at the UBS Global Healthcare Conference 2015 Business Wire
May-11-15 04:55PM  GTX INC /DE/ Files SEC form 10-Q, Quarterly Report
May-08-15 09:00AM  GTX Inc Earnings Call scheduled for 9:00 am ET today +11.84%
07:31AM  GTX INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:27AM  GTx reports 1Q loss
07:07AM  Q1 2015 GTX Inc Earnings Release - Before Market Open
07:00AM  GTx Provides Corporate Update and Reports First Quarter 2015 Financial Results Business Wire
Apr-30-15 02:33PM  3 Stocks Under $10 to Trade for Big Breakouts at TheStreet
Apr-23-15 07:34AM  GTx and the University of Tennessee Research Foundation Enter Into Exclusive License Agreement to Develop UTRFs SARD Drug Technology at noodls
07:32AM  GTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:00AM  GTx and the University of Tennessee Research Foundation Enter Into Exclusive License Agreement to Develop UTRFs SARD Drug Technology Business Wire
Apr-22-15 08:10PM  10-K for GTx, Inc. at Company Spotlight
Apr-17-15 05:02PM  GTX INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligatio
Apr-02-15 07:31AM  GTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:15AM  GTx Provides Corporate Update Regarding NASDAQ Stock Listing at noodls
07:00AM  GTx Provides Corporate Update Regarding NASDAQ Stock Listing Business Wire
Mar-20-15 04:31PM  GTX INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tran -5.26%
Mar-18-15 10:39AM  GIGABYTE Launches GeForce┬« GTX TITAN X. The Most Advanced GPU Ever Built! at noodls
Mar-16-15 04:49PM  GTX INC /DE/ Files SEC form 10-K, Annual Report
Mar-13-15 09:00AM  ASUS' new gaming laptop packs NVIDIA's latest graphics card at Engadget
Mar-11-15 12:08AM  GTx, Inc. to Host Fourth Quarter and Full Year 2014 Financial Results Conference Call and Webcast at noodls
12:08AM  GTx Provides Corporate Update and Reports Fourth Quarter and Year-End 2014 Financial Results at noodls
Mar-05-15 11:12AM  GTX 960 processor increases Nvidias share in the gaming space +10.53%
07:53AM  Can the Rally in GTX Inc (GTXI) Shares Continue? - Tale of the Tape
Mar-04-15 04:32PM  GTX INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tran -5.00%
09:00AM  GTX Inc Earnings Call scheduled for 9:00 am ET today
07:00AM  GTx Provides Corporate Update and Reports Fourth Quarter and Year-End 2014 Financial Results Business Wire
Feb-19-15 05:01PM  GTX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online +13.64%
07:00AM  GTx, Inc. to Host Fourth Quarter and Full Year 2014 Financial Results Conference Call and Webcast Business Wire
Feb-17-15 07:23AM  GTx Appoints Robert J. Wills, Ph.D. to Board of Directors at noodls
07:00AM  GTx Appoints Robert J. Wills, Ph.D. to Board of Directors Business Wire
Feb-12-15 05:12PM  Nvidia GeForce GTX 960 Review Part II: 1440p Benchmarks, 2-Way SLI, And Radeon 285 Showdown at Forbes
GTx, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecules for the treatment of breast and prostate cancer, and other serious medical conditions. The company is developing selective androgen receptor modulators to treat a range of serious diseases, including breast cancer, stress urinary incontinence, and Duchenne muscular dystrophy; and selective androgen receptor degrader for the treatment of castration resistant prostate cancer. Its products include enobosarm, a Phase II open-label proof-of-concept clinical trial for patients with advanced AR positive TNBC and ER positive/AR positive advanced breast cancer, as well as postmenopausal women with SUI. GTx, Inc. was founded in 1997 and is headquartered in Memphis, Tennessee.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wills Robert JamesExecutive ChairmanJun 16Buy0.65100,00065,3601,200,000Jun 20 10:19 AM
GLASS J KENNETHDirectorMar 01Buy0.6044,00026,400183,768Mar 02 05:03 PM
HANOVER MARC STEVENChief Executive OfficerJan 26Buy0.654,0002,6001,257,224Jan 26 04:40 PM
HANOVER MARC STEVENChief Executive OfficerJan 19Buy0.5025,00012,4281,240,411Jan 19 05:06 PM
HANOVER MARC STEVENChief Executive OfficerJan 15Buy0.4922,10010,8891,215,411Jan 15 01:59 PM
HANOVER MARC STEVENChief Executive OfficerJan 14Buy0.472,9001,3771,193,311Jan 15 01:59 PM
GLASS J KENNETHDirectorDec 24Buy0.7910079139,768Dec 28 05:07 PM
GLASS J KENNETHDirectorDec 21Buy0.7839,90031,122137,761Dec 21 05:12 PM